Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure

Institute of Liver and Biliary Sciences, India

Status: Completed

Conditions: Acute Liver Failure; Cirrhosis; Chronic Liver Failure

Study type: Observational

Funder types: Other

Identifiers

NCT01872767

ILBS-ACLF-0003

Details and patient eligibility

About

After successful screening diagnosis of cirrhosis and/or acute or chronic liver failure will be made. These patients will undergo detail clinical, biochemical and microbiological examination at baseline. Clinical examination and Biochemical evaluation will be done daily and signs of infection will be noted. Patients will undergo microbiological screening for infection every 48 hours. Patients suspected or diagnosed to be suffering from infections will be treated as per ILBS (Institute of Liver and Biliary Sciences) antibiotic policy. Site and etiology (bacterial and/or fungal) of infections will be noted in all patients at admission in liver specialty ICU (Intensive Care Unit) and during the ICU (Intensive Care Unit) stay. All the patients will be followed until discharge or death in ICU (Intensive Care Unit).

Enrollment: 522 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A clinical, radiological or histological diagnosis of cirrhosis and/or ACLF (Acute on Chronic Liver Failure).
• Age > 18years

Exclusion criteria

• Previous liver transplantation.
• Patients who died within 8 hours of ICU (Intensive Care Unit) admission.
• Acute liver failure
• Lack of consent
• Patient on steroids/ or any other immunosuppressive medication

Trial design

522 participants in 1 patient group

Cirrhotics/ Acute on chronic liver failure admitted to ICU